667 related articles for article (PubMed ID: 30413179)
21. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation.
Wu X; Hu J; Zhou L; Mao Y; Yang B; Gao L; Xie R; Xu F; Zhang D; Liu J; Zhu J
J Neurosurg; 2008 Feb; 108(2):320-9. PubMed ID: 18240929
[TBL] [Abstract][Full Text] [Related]
22. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.
Kelly JJ; Stechishin O; Chojnacki A; Lun X; Sun B; Senger DL; Forsyth P; Auer RN; Dunn JF; Cairncross JG; Parney IF; Weiss S
Stem Cells; 2009 Aug; 27(8):1722-33. PubMed ID: 19544433
[TBL] [Abstract][Full Text] [Related]
23. Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.
Choi SA; Lee JY; Kwon SE; Wang KC; Phi JH; Choi JW; Jin X; Lim JY; Kim H; Kim SK
PLoS One; 2015; 10(6):e0129292. PubMed ID: 26076490
[TBL] [Abstract][Full Text] [Related]
24. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
[TBL] [Abstract][Full Text] [Related]
25. Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies.
Bajetto A; Thellung S; Dellacasagrande I; Pagano A; Barbieri F; Florio T
Stem Cells Transl Med; 2020 Nov; 9(11):1310-1330. PubMed ID: 32543030
[TBL] [Abstract][Full Text] [Related]
26. Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors.
Bajetto A; Pattarozzi A; Corsaro A; Barbieri F; Daga A; Bosio A; Gatti M; Pisaturo V; Sirito R; Florio T
Front Cell Neurosci; 2017; 11():312. PubMed ID: 29081734
[TBL] [Abstract][Full Text] [Related]
27. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury.
Ji JF; He BP; Dheen ST; Tay SS
Stem Cells; 2004; 22(3):415-27. PubMed ID: 15153618
[TBL] [Abstract][Full Text] [Related]
28. Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells.
Venugopal C; Li N; Wang X; Manoranjan B; Hawkins C; Gunnarsson T; Hollenberg R; Klurfan P; Murty N; Kwiecien J; Farrokhyar F; Provias JP; Wynder C; Singh SK
Stem Cell Res; 2012 Mar; 8(2):141-53. PubMed ID: 22265735
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133.
Cho JH; Kim AR; Kim SH; Lee SJ; Chung H; Yoon MY
Acta Biomater; 2017 Jan; 47():182-192. PubMed ID: 27721007
[TBL] [Abstract][Full Text] [Related]
31. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
[TBL] [Abstract][Full Text] [Related]
32. MRI tracking of polyethylene glycol-coated superparamagnetic iron oxide-labelled placenta-derived mesenchymal stem cells toward glioblastoma stem-like cells in a mouse model.
Hsu FT; Wei ZH; Hsuan YC; Lin W; Su YC; Liao CH; Hsieh CL
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S448-S459. PubMed ID: 30198338
[TBL] [Abstract][Full Text] [Related]
33. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
34. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.
Ponte AL; Marais E; Gallay N; Langonné A; Delorme B; Hérault O; Charbord P; Domenech J
Stem Cells; 2007 Jul; 25(7):1737-45. PubMed ID: 17395768
[TBL] [Abstract][Full Text] [Related]
35. Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma.
Motaln H; Gruden K; Hren M; Schichor C; Primon M; Rotter A; Lah TT
Cell Transplant; 2012; 21(7):1529-45. PubMed ID: 22554389
[TBL] [Abstract][Full Text] [Related]
36. Brain tumor stem cells from an adenoid glioblastoma multiforme.
Oka N; Soeda A; Noda S; Iwama T
Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857
[TBL] [Abstract][Full Text] [Related]
37. Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury.
Nichols JE; Niles JA; DeWitt D; Prough D; Parsley M; Vega S; Cantu A; Lee E; Cortiella J
Stem Cell Res Ther; 2013 Jan; 4(1):3. PubMed ID: 23290300
[TBL] [Abstract][Full Text] [Related]
38. CD133 is essential for glioblastoma stem cell maintenance.
Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
[TBL] [Abstract][Full Text] [Related]
39. Specific chemotaxis of magnetically labeled mesenchymal stem cells: implications for MRI of glioma.
Bennewitz MF; Tang KS; Markakis EA; Shapiro EM
Mol Imaging Biol; 2012 Dec; 14(6):676-87. PubMed ID: 22418788
[TBL] [Abstract][Full Text] [Related]
40. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
